Study guide
5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation
Certified Burn Registered Nurse CBRN
Track your progress as you read
Finished sections get a check mark.
1 Chapter 1: Introduction & Foundations of Burn Care
1.1 CBRN Exam Format, Eligibility, and BCEN Testing Standards 1.2 Anatomy, Histology, and Barrier Functions of the Skin 1.3 Burn Depth Classification and Jackson's Thermal Wound Zones
2 Chapter 2: Pathophysiology of Burn Injury & Systemic Response
2.1 Cellular Pathophysiology and Capillary Permeability in Burn Shock 2.2 Systemic Inflammatory Response Syndrome (SIRS) and MODS 2.3 Pathophysiology of Supraglottic, Subglottic, and Inhalational Injury 2.4 Cellular Phases of Burn Wound Healing and Scar Pathobiology
3 Chapter 3: Prehospital Triage, Primary Survey & Transfer Criteria
3.1 Initial Assessment, Primary Survey (ABCDEF), and Field Stabilization 3.2 Total Body Surface Area (TBSA) Calculation: Rule of Nines, Lund-Browder, and Palmar Method 3.3 American Burn Association (ABA) Burn Center Referral Criteria and Transport Logistics
4 Chapter 4: Fluid Resuscitation & Hemodynamic Stabilization (<72 Hours)
4.1 Fluid Resuscitation Formulas: Parkland (Baxter), Modified Brooke, and Consensus Protocols 4.2 Resuscitation Endpoints: Urine Output Titration, Base Deficit, and Hemodynamic Monitoring 4.3 Complications of Fluid Creep and Intra-Abdominal Hypertension / Abdominal Compartment Syndrome 4.4 Extremity Compartment Syndrome, Monitoring, and Emergent Escharotomy / Fasciotomy
5 Chapter 5: Airway Management & Inhalation Injury Management
5.1 Upper Airway Compromise, Indications for Early Endotracheal Intubation, and Airway Stabilization 5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation 5.3 Carbon Monoxide (CO) Toxicity, Cyanide Poisoning, and Specific Antidotes (Hydroxocobalamin)
6 Chapter 6: Acute Multisystem Assessment & Critical Care Management
6.1 Cardiovascular Derangements, Myocardial Depression, and Hemodynamic Optimization 6.2 Acute Kidney Injury, Rhabdomyolysis / Myoglobinuria, and Fluid-Electrolyte Shifts 6.3 Gastrointestinal Complications, Ileus, Early Enteral Nutrition, and Curling's Ulcer Prophylaxis 6.4 Neurological Impairment, Anemia of Burn Injury, Coagulopathy, and Musculoskeletal Protection
7 Chapter 7: Hypermetabolism & Nutritional Support
7.1 The Biphasic Metabolic Response: Ebb vs. Flow Phases and Persistent Hypermetabolism 7.2 Indirect Calorimetry, Caloric Equations (Curreri/Toronto), and Micronutrient / Trace Mineral Needs 7.3 Pharmacological Modulation: Propranolol, Oxandrolone, Growth Hormone, and Exercise Therapy 7.4 Stress Hyperglycemia, Intensive Insulin Protocols, and Adrenal / Thyroid Axis Dysregulation
8 Chapter 8: Pain Management in Burn Care
8.1 Pain Classification in Burns: Background, Procedural, Breakthrough, and Chronic Neuropathic Pain 8.2 Multimodal Analgesia: Opioids, Ketamine, Gabapentinoids, NSAIDs, and Regional Anesthesia 8.3 Non-Pharmacological Modalities: Virtual Reality, Cognitive Behavioral Techniques, Hypnosis, and Distraction
9 Chapter 9: Agitation, Delirium & Post-Burn Pruritus
9.1 Agitation Management, Targeted Sedation Protocols (RASS/SAS), and Circadian Rhythm Support 9.2 ICU Delirium: Risk Factors, Screening (CAM-ICU/ICDSC), Non-Pharmacological Bundles, and Medical Management 9.3 Post-Burn Itch: Histaminergic vs. Neuropathic Pruritus, Oral Antihistamines, Gabapentin, and Topical Emollients
10 Chapter 10: Burn Wound Assessment, Topical Antimicrobials & Dressings
10.1 Serial Wound Bed Assessment, Tissue Perfusion, and Documentation Standards 10.2 Topical Antimicrobial Formulations: Silver Sulfadiazine, Mafenide Acetate, Silver Nitrate, and Modern Silver Dressings 10.3 Wound Bed Preparation: Surgical, Enzymatic (Collagenase/Bromelain), Autolytic, and Mechanical Debridement 10.4 Modern Dressings, Hydrogels, Foam Dressings, Negative Pressure Wound Therapy (NPWT), and Moisture Retentive Balances
11 Chapter 11: Surgical Excision, Skin Grafting & Wound Closure
11.1 Principles of Early Tangential vs. Fascial Surgical Excision and Blood Conservation 11.2 Split-Thickness and Full-Thickness Autografting: Mesh Expansion Ratios vs. Sheet Grafts 11.3 Biologic Coverings, Dermal Regeneration Templates (Integra/Novosorb BTM), Allograft, and Xenograft 11.4 Autologous Cell Suspensions (ReCell), Cultured Epithelial Autografts (CEA), and Donor Site Management
12 Chapter 12: Burn Sepsis, Infection Control & Antimicrobial Therapy
12.1 Burn Center Infection Control: Contact Precautions, Hydrotherapy Sanitation, and Environmental Controls 12.2 Differentiating Hypermetabolic SIRS from Burn Sepsis: ABA Consensus Sepsis Criteria 12.3 Common Burn Pathogens (Pseudomonas, MRSA, Acinetobacter, Candida, Aspergillus) and Empiric Coverage 12.4 Invasive Burn Wound Infection: Clinical Signs, Quantitative Biopsy (>10^5 CFU/g), and Histopathological Invasion
13 Chapter 13: Specific Burn Etiologies: Electrical, Chemical & Cold Injuries
13.1 Electrical Burn Injuries: High-Voltage vs. Low-Voltage, Arc/Flash, Cardiac Monitoring, and Deep Muscle Necrosis 13.2 Chemical Injuries: Acids (Coagulation Necrosis), Alkalis (Liquefactive Necrosis), Hydrofluoric Acid (Calcium Gluconate), and Decontamination 13.3 Radiation Burns, Cutaneous Radiation Syndrome, Cold Injuries (Frostbite Triage and Thawing Protocols), and Vasodilator Therapy
14 Chapter 14: Special Burn Populations & Cutaneous Syndromes
14.1 Pediatric Burn Resuscitation (Maintenance Fluids + D5W), Surface Area Dynamics, and Non-Accidental Trauma Screening 14.2 Geriatric Burn Care: Thin Dermis, Altered Fluid Tolerance, Pre-existing Comorbidities, and Mortality Prognostication (Baux Score) 14.3 Burn Injury in Pregnancy: Maternal Physiology, Resuscitation, and Fetal Surveillance 14.4 Severe Cutaneous Adverse Reactions: Stevens-Johnson Syndrome (SJS), Toxic Epidermal Necrolysis (TEN), SCORTEN, and Specialized Burn Unit Nursing 14.5 Necrotizing Soft Tissue Infections and Friction/Shear Injuries
15 Chapter 15: Rehabilitation, Scar Management & Reconstruction
15.1 Anti-Deformity Positioning, Range-of-Motion Exercises, and Custom Splinting Across Major Joints 15.2 Hypertrophic Scarring Mechanisms, Myofibroblasts, and Vancouver Scar Scale (VSS) Assessment 15.3 Custom Pressure Garments (20-30 mmHg), Silicone Sheeting, Fractional CO2 Laser Resurfacing, and Contracture Release 15.4 Psychosocial Recovery, Post-Traumatic Stress Disorder (PTSD), Body Image Adaptation, Peer Support (Phoenix Society), and School/Work Reintegration 15.5 Discharge Teaching, Transition to Ambulatory Care, and Home Management
16 Chapter 16: Professional Practice, Ethics, Quality & Disaster Triage
16.1 Ethical Dilemmas in Burn Critical Care, Surrogate Decision-Making, Futility, and Palliative / End-of-Life Symptom Management 16.2 Interprofessional Burn Team Roles, Multidisciplinary Rounds, Structured Handoffs, and Patient/Family Advocacy 16.3 Burn Quality Improvement, American Burn Association (ABA) Verification Standards, and National Burn Repository (NBR) Benchmarking 16.4 Diversity, Equity, Inclusion, and Intraprofessional Nursing Development 16.5 Community Outreach, Burn Prevention Education, and Home Safety 16.6 Mass Casualty Burn Disasters, Secondary Triage Schemes (ABA/ABLS Triage Matrix), Surge Capacity, and CBRN/HAZMAT Emergency Response
5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation
Key Takeaways Explain This Topic AI
Lower airway inhalation injury is primarily a chemical insult caused by toxic combustion products (aldehydes, acrolein, hydrochloric acid) destroying the pseudostratified ciliated columnar epithelium and mucociliary escalator.
Chemical injury triggers an intense inflammatory cascade that increases bronchial blood flow 10- to 20-fold, generating massive plasma transudation and dense fibrin-cellular casts that occlude small airways.
Diagnostic fiberoptic bronchoscopy is the gold standard for confirming and grading inhalation injury using the Abbreviated Injury Score (AIS) scale from Grade 0 (None) to Grade 4 (Massive mucosal sloughing and necrosis).
Evidence-based aerosol therapy combines alternating nebulized unfractionated heparin (5,000–10,000 units q4h) and 20% N-acetylcysteine (NAC q4h) with bronchodilators to digest fibrin casts, thin secretions, and reduce airway resistance.
Mechanical ventilation for burn ARDS requires lung-protective parameters (tidal volume 4–6 mL/kg predicted body weight, plateau pressure < 30 cm H2O, driving pressure < 15 cm H2O), High-Frequency Percussive Ventilation (HFPV) for cast clearance, and prone positioning.
Last updated: August 2026
5.2 Lower Airway Chemical Tracheobronchitis, Diagnostic Bronchoscopy, and Lung-Protective Mechanical Ventilation
Core Knowledge: Inhalation injury below the vocal cords is predominantly a chemical tracheobronchitis and parenchymal insult rather than a direct thermal burn. Toxic combustion byproducts dissolve in the airway lining fluid, destroying the pseudostratified ciliated epithelium, impairing the mucociliary escalator, and triggering a 10- to 20-fold surge in bronchial blood flow. The resulting protein-rich transudate, necrotic cellular debris, and fibrin mesh form thick, obstructing endobronchial casts. Management hinges on early diagnostic bronchoscopy, aggressive aerosolized pharmacotherapy (heparin/NAC/bronchodilators), and lung-protective mechanical ventilation to mitigate acute respiratory distress syndrome (ARDS).
Pathophysiology of Chemical Tracheobronchitis and Parenchymal Injury
When smoke enters the tracheobronchial tree, toxic gases (such as acrolein, formaldehyde, sulfur dioxide, hydrochloric acid, and phosgene) interact with mucosal moisture, forming concentrated acids and alkalis. ┌────────────────────────────────────────────────────────────────────────┐
- │ LOWER AIRWAY CHEMICAL INHALATION INJURY CASCADE │
- │ │
- │ Inhalation of Toxic Combustion Chemicals (Aldehydes, Acrolein, HCl) │
- │ │ │
- │ ▼ │
- │ Epithelial Necrosis & Loss of Pseudostratified Ciliated Cells │
- │ (Paralysis of Mucociliary Escalator & Loss of Surfactant) │
- │ │ │
- │ ▼ │
- │ Intense Neurogenic & Cytokine Inflammation (Substance P, IL-8, ROS) │
- │ │ │
- │ ▼ │
- │ Bronchial Microvascular Hyperemia (10x to 20x Increase in Blood Flow) │
- │ │ │
- │ ▼ │
- │ Massive Transudation of Plasma Proteins, Fibrinogen & Neutrophils │
- │ │ │
- │ ▼ │
- │ Formation of Occlusive Endobronchial Fibrin-Cellular Casts │
- │ │ │
- │ ┌────────────────────────┴────────────────────────┐ │
- │ ▼ ▼ │
- │ Segmental Atelectasis & Air Trapping Severe V/Q Mismatch │
- │ (Secondary Bacterial Bronchopneumonia) & Fulminant ARDS │
- └────────────────────────────────────────────────────────────────────────┘
- 1. Epithelial Destruction and Mucociliary Failure
The normal tracheobronchial tree is lined by pseudostratified ciliated columnar epithelium interspersed with goblet cells. Toxic chemicals denude this mucosal layer, causing cellular apoptosis, basement membrane separation, and immediate paralysis of the mucociliary escalator . Without functional cilia, the lung loses its primary mechanical clearance mechanism for inhaled particulates, bacteria, and sloughed cells.
2. Bronchial Hypervascularity and Transudation
Chemical irritation stimulates sensory C-fibers, releasing neuropeptides (substance P, calcitonin gene-related peptide) and triggering massive neutrophil recruitment. This generates an astonishing 10- to 20-fold increase in bronchial arterial blood flow . The hyperemic bronchial circulation leaks enormous quantities of plasma proteins, fluid, and fibrinogen into the airway lumen.
3. Cast Formation and Airway Obstruction
Within the airway lumen, extravasated fibrinogen encounters tissue factor, activating the coagulation cascade and polymerizing into a dense fibrin network . This fibrin mesh traps sloughed epithelial cells, neutrophils, mucus, and soot particulates, coalescing into thick, rubbery, branching bronchial casts .
Pathological Consequences: These casts act as one-way ball-valves, causing distal hyperinflation and air trapping, or complete luminal obstruction leading to segmental and lobar atelectasis.
V/Q Mismatch and Infection: Occluded lung segments suffer profound ventilation-perfusion (V/Q) mismatch and intrapulmonary shunting. Furthermore, non-viable cast material serves as a nutrient-rich culture medium for opportunistic pathogens ( Pseudomonas aeruginosa , Staphylococcus aureus ), dramatically increasing the incidence of bacterial bronchopneumonia .
Diagnostic Fiberoptic Bronchoscopy & AIS Grading
Fiberoptic bronchoscopy is the universally recognized gold standard for confirming the diagnosis, establishing baseline injury severity, and guiding therapeutic pulmonary toilet. ┌─────────────────────────────────────────┐
- │ ABBREVIATED INJURY SCORE (AIS) GRADING │
- └────────────────────┬────────────────────┘
- │
- ┌───────────────────────────────┼───────────────────────────────┐
- ▼ ▼ ▼
- ┌──────────────────┐ ┌──────────────────┐ ┌──────────────────┐
- │ GRADE 1: MILD │ │ GRADE 2: MODERATE│ │ GRADE 3: SEVERE │
- │• Patchy erythema │ │• Marked erythema │ │• Severe ulceration
- │• Carbon deposits │ │• Moderate edema │ │• Deep necrosis │
- │• No ulceration │ │• Copious mucus │ │• Thick casts │
- └──────────────────┘ └──────────────────┘ └──────────────────┘
- │
- ▼
- ┌──────────────────┐
- │ GRADE 4: MASSIVE │
- │• Complete slough │
- │• Luminal closure │
- │• True obstruction│
- └──────────────────┘
- The AIS Bronchoscopy Grading Scale
AIS Grade Severity Bronchoscopic Endoscopic Findings Clinical Implications
Grade 0 None Normal, intact pink mucosa; no soot deposits; sharp carina Inhalation injury excluded; standard ventilator weaning
Grade 1 Mild Minor patchy erythema; localized soot particles; no mucosal sloughing Low risk of ARDS; aggressive chest physiotherapy
Grade 2 Moderate Marked diffuse erythema; significant mucosal edema; moderate soot deposits; non-obstructing secretions Aerosolized heparin/NAC protocol indicated; frequent toilet
Grade 3 Severe Extensive mucosal ulceration, paleness, or deep friability; significant necrosis; thick endobronchial casts High risk of ARDS and pneumonia; intensive therapeutic bronchoscopy
Grade 4 Massive Complete mucosal sloughing; deep circumferential charring and necrosis; widespread endobronchial cast obstruction Severe refractory ARDS; candidate for advanced modalities (HFPV/ECMO)
Therapeutic Pulmonary Hygiene and Pharmacological Adjuncts
Pharmacological management of lower airway injury focuses on lysing fibrin casts, thinning secretions, and reversing reactive bronchospasm. ┌──────────────────────────────────────────┐
- │ EVIDENCE-BASED INHALED AEROSOL REGIMEN │
- └────────────────────┬─────────────────────┘
- │
- ┌────────────────────────┴────────────────────────┐
- ▼ ▼
- ┌───────────────────────────────┐ ┌────────────────────────────────┐
- │ AEROSOLIZED HEPARIN (q4h) │ │ AEROSOLIZED NAC 20% (q4h) │
- │• 5,000–10,000 units in 3 mL NS│ │• 3–5 mL 20% solution │
- │• Inhibits thrombin conversion │ │• Cleaves disulfide bonds in │
- │ of fibrinogen to fibrin │ │ mucus & cast proteins │
- │• Prevents new cast formation │ │• Thins tenacious secretions │
- └────────────┬──────────────────┘ └────────────────┬───────────────┘
- │ │
- └────────────────────────┬────────────────┘
- ▼
- ┌────────────────────────────────┐
- │ INHALED BRONCHODILATORS │
- │• Albuterol (2.5 mg) │
- │• Ipratropium (0.5 mg) │
- │• Counters reactive spasm & │
- │ protects against NAC-spasm │
- └────────────────────────────────┘
- 1. Inhaled Aerosolized Unfractionated Heparin
Mechanism: Inhaled heparin inhibits thrombin-mediated conversion of fibrinogen to fibrin on the denuded mucosal surface, directly halting the construction of the structural scaffold required for cast formation.
Dosing: 5,000 to 10,000 units dissolved in 3 mL normal saline via nebulizer every 4 hours.
Systemic Safety: Aerosolized heparin works locally on the pulmonary mucosa; systemic absorption is negligible, meaning it does not alter systemic coagulation parameters (PT/INR or aPTT) and does not increase surgical bleeding risk during burn debridement.
2. Inhaled Aerosolized N-Acetylcysteine (NAC)
Mechanism: NAC is a potent mucolytic that hydrolyzes the disulfide bonds connecting mucoprotein molecules, dissolving thick mucus and loosening necrotic casts.
Dosing: 3 to 5 mL of 20% solution (or 6–10 mL of 10% solution) nebulized every 4 hours, typically alternated with heparin.
Precaution: NAC can induce reactive bronchospasm in hyperreactive airways. It must always be co-administered with or preceded by an inhaled beta-2 agonist.
3. Inhaled Bronchodilators
Agents: Nebulized Albuterol (2.5 mg) and Ipratropium bromide (0.5 mg) administered every 4 to 6 hours.
Purpose: Relieves severe smooth muscle bronchospasm induced by chemical toxins, decreases airway resistance, and enhances mucociliary and cough clearance.
4. Aggressive Physical Pulmonary Toilet
Therapeutic Bronchoscopy: Performed as needed to mechanically visualize, irrigate, grasp, and aspirate large occlusive casts from lobar and segmental orifices.
Chest Physiotherapy (CPT): High-frequency chest wall oscillation (the Vest), manual percussion/postural drainage, and early progressive out-of-bed mobilization.
Lung-Protective Mechanical Ventilation in Burn ARDS
Acute Respiratory Distress Syndrome (ARDS) develops in up to 30–50% of patients with severe inhalation injury combined with major cutaneous burns. Management requires strict adherence to evidence-based lung-protective ventilation.
Ventilator Parameter Target Setting / Range Physiological Rationale
Tidal Volume ( V T V_T V T ) 4 to 6 mL/kg of Predicted Body Weight (PBW) Prevents volutrauma and alveolar overdistension in heterogeneously aerated lungs
Plateau Pressure ( P p l a t P_{plat} P pl a t ) < 30 cm H₂O Eliminates excessive alveolar distending pressure and microvascular shear stress
Driving Pressure (Delta P) < 15 cm H₂O (Delta P = Pplat - PEEP) Optimizes transpulmonary strain; lowest driving pressure correlates with decreased mortality
PEEP Titration 10 to 18 cm H₂O (titrated via PEEP/FiO2 table) Prevents cyclic end-expiratory alveolar collapse (atelectrauma) and maintains functional residual capacity
Permissive Hypercapnia Target arterial pH 7.20 to 7.25 (PaCO2 50–70 mmHg) Prioritizes lung protection over normal blood gases; avoids excessive minute ventilation
Important
Always Calculate Predicted Body Weight (PBW): Burn patients accumulate tens of kilograms of edema during resuscitation. Never set tidal volumes using the patient's actual recorded bed scale weight. Doing so causes massive volutrauma. Calculate PBW using standardized height and biological sex equations:
Male PBW (kg): 50 + 0.91 × ( Height in cm − 152.4 ) 50 + 0.91 \times (\text{Height in cm} - 152.4) 50 + 0.91 × ( Height in cm − 152.4 )
Female PBW (kg): 45.5 + 0.91 × ( Height in cm − 152.4 ) 45.5 + 0.91 \times (\text{Height in cm} - 152.4) 45.5 + 0.91 × ( Height in cm − 152.4 )
Advanced Ventilatory Modes and Rescue Strategies
When conventional lung-protective ventilation fails to maintain oxygenation or when endobronchial cast burden is severe, specialized modalities are utilized.
1. High-Frequency Percussive Ventilation (HFPV / Volara / VDR-4)
Mechanism: HFPV delivers high-frequency sub-deadspace percussive breaths (rates of 200 to 600 cycles/min) superimposed on a standard low-frequency, pressure-controlled breathing cycle.
Advantages in Inhalation Injury:
The percussive pressure waves travel down the core of the airway lumen, vibrating and shearing thick, adherent casts off the bronchial walls.
Exhaled gas moves along the outer circumference of the airway, sweeping loosened secretions and soot upward toward the trachea for easy suctioning.
Enhances diffusive gas exchange at low peak and mean airway pressures, minimizing barotrauma.
2. Prone Positioning in Burn ARDS
Indication: Severe ARDS with a PaO 2 / FiO 2 \text{PaO}_2 / \text{FiO}_2 PaO 2 / FiO 2 ratio < 150 despite optimization of PEEP and recruitment.
Mechanism: Prone positioning (for ≥ 16 consecutive hours daily ) unweights the dorsal lung segments, homogenizes pleural pressure gradients, dramatically reduces V/Q mismatch, and improves drainage of secretions.
Burn Nursing Considerations: Prone positioning in major burns requires meticulous coordination: protecting autografts and donor sites from shear stress, rigorous facial foam padding to prevent orbital compartment syndrome and pressure ulcers, and securing the ETT to prevent catastrophic accidental extubation during rotation.